Table 3.

Multivariable regression PSP after 6 weeks adjusting for treatment and the mediators PANSS score, WG, and SAS score

	Paliperidone 3 mg	Paliperidone 9 mg	Paliperidone 15 mg
Treatment	3.34 (−1.29, 7.98)	5.05 (1.32, 8.78)	6.61 (2.04, 11.18)
WG	73.28 (18.97, 127.59)	34.04 (−5.83, 73.91)	51.36 (11.16, 91.55)
WG_sq	−223.83 (−424.72, −22.94)	−177.01 (−347.44, −6.58)	−201.68 (−366.99, −36.37)
PANSS	−0.91(−1.16, −0.66)	−0.82 (−1.06, −0.58)	−0.81 (−1.05, −0.57)
Max SAS	0.92 (V0.66, 2.50)	0.31 (−0.69, 1.32)	0.80 (−0.21, 1.82)

All models adjusted for age, sex, race, country, relative day of disease onset, total PANSS score at baseline, PSP score at baseline, BARS score at baseline, SAS score at baseline, BMI at baseline. We report pooled estimates (pooled confidence intervals) from 50 multiple imputations